Interaction of ncRNAs and the PI3K/AKT/mTOR pathway: Implications for osteosarcoma

被引：1

作者：

Shao, Weilin ^{[1
]}

Feng, Yan ^{[1
]}

Huang, Jin ^{[1
]}

Li, Tingyu ^{[3
]}

Gao, Shengguai ^{[3
]}

Yang, Yihao ^{[1
]}

Li, Dongqi ^{[1
]}

Yang, Zuozhang ^{[1
]}

Yao, Zhihong ^{[1
,2
]}

机构：

[1] Kunming Med Univ, Yunnan Canc Hosp, Bone & Soft Tissue Tumours Res Ctr Yunnan Prov, Yunnan Canc Ctr,Affiliated Hosp 3,Dept Orthopaed, 519 Kunzhou Rd, Kunming 650118, Yunnan, Peoples R China

[2] Kunming Med Univ, Yunnan Canc Hosp, Yunnan Canc Ctr, Affiliated Hosp 3,Dept Canc,Res Inst, 519 Kunzhou Rd, Kunming 650118, Yunnan, Peoples R China

[3] Kunming Med Univ, Clin Oncol Inst, Kunming 650500, Yunnan, Peoples R China

来源：

OPEN LIFE SCIENCES | 2024年 / 19卷 / 01期

基金：

美国国家科学基金会;

关键词：

osteosarcoma; PI3K/AKT/mTOR; ncRNAs; biomarkers; therapeutic targets; PROMOTES CELL-PROLIFERATION; SIGNALING PATHWAY; NONCODING RNA; CISPLATIN RESISTANCE; DOWN-REGULATION; TUMOR PROGRESSION; CIRCULAR RNAS; UP-REGULATION; GROWTH; INVASION;

D O I：

10.1515/biol-2022-0936

中图分类号：

Q [生物科学];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

Osteosarcoma (OS) is the most common primary malignant bone tumor in children and adolescents, and is characterized by high heterogeneity, high malignancy, easy metastasis, and poor prognosis. Recurrence, metastasis, and multidrug resistance are the main problems that limit the therapeutic effect and prognosis of OS. PI3K/AKT/mTOR signaling pathway is often abnormally activated in OS tissues and cells, which promotes the rapid development, metastasis, and drug sensitivity of OS. Emerging evidence has revealed new insights into tumorigenesis through the interaction between the PI3K/AKT/mTOR pathway and non-coding RNAs (ncRNAs). Therefore, we reviewed the interactions between the PI3K/AKT/mTOR pathway and ncRNAs and their implication in OS. These interactions have the potential to serve as cancer biomarkers and therapeutic targets in clinical applications.

引用

页数：14

共 50 条

[21] Prospects of targeting PI3K/AKT/mTOR pathway in pancreatic cancer [J].

Mortazavi, Motahareh ;

Moosavi, Fatemeh ;

Martini, Miriam ;

Giovannetti, Elisa ;

Firuzi, Omidreza .

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2022, 176

[22] Targeting the PI3K/Akt/mTOR Pathway for Breast Cancer Therapy [J].

Cidado, Justin ;

Park, Ben Ho .

JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA, 2012, 17 (3-4) :205-216

[23] The PI3K/AKT/mTOR signaling pathway in osteoarthritis: a narrative review [J].

Sun, K. ;

Luo, J. ;

Guo, J. ;

Yao, X. ;

Jing, X. ;

Guo, F. .

OSTEOARTHRITIS AND CARTILAGE, 2020, 28 (04) :400-409

[24] Targeting the PI3K/Akt/mTOR signalling pathway in Cystic Fibrosis [J].

Reilly, R. ;

Mroz, M. S. ;

Dempsey, E. ;

Wynne, K. ;

Keely, S. J. ;

McKone, E. F. ;

Hiebel, C. ;

Behl, C. ;

Coppinger, J. A. .

SCIENTIFIC REPORTS, 2017, 7

[25] PI3K/Akt/mTOR signaling pathway in cancer stem cells [J].

Fath, Mohsen Karami ;

Ebrahimi, Menooa ;

Nourbakhsh, Ehsan ;

Hazara, Ahmad Zia ;

Mirzaei, Ali ;

Shafieyari, Saba ;

Salehi, Azadeh ;

Hoseinzadeh, Mahsa ;

Payandeh, Zahra ;

Barati, Ghasem .

PATHOLOGY RESEARCH AND PRACTICE, 2022, 237

[26] Inhibition of PI3K/AKT/mTOR pathway for the treatment of endometriosis Reply [J].

Matsuzaki, Sachiko ;

Pouly, Jean-Luc ;

Canis, Michel .

BRITISH JOURNAL OF PHARMACOLOGY, 2018, 175 (17) :3628-3629

[27] RILP inhibits tumor progression in osteosarcoma via Grb10-mediated inhibition of the PI3K/AKT/mTOR pathway [J].

Wei, Zhun ;

Xia, Kezhou ;

Zheng, Di ;

Gong, Changtian ;

Guo, Weichun .

MOLECULAR MEDICINE, 2023, 29 (01)

[28] Tizanidine hydrochloride exhibits a cytotoxic effect on osteosarcoma cells through the PI3K/AKT signaling pathway [J].

Xing, Xue-Wu ;

Sun, Yu-Fu ;

Zhao, Jun ;

Pan, Zi-Xiang ;

Jiang, Wen-Xue .

JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2019, 47 (08) :3792-3802

[29] MALAT1 promotes the proliferation and metastasis of osteosarcoma cells by activating the PI3K/Akt pathway [J].

Dong, Yongqiang ;

Liang, Guojun ;

Yuan, Bo ;

Yang, Chaoqun ;

Gao, Rui ;

Zhou, Xuhui .

TUMOR BIOLOGY, 2015, 36 (03) :1477-1486

[30] Arnicolide D Inhibits Proliferation and Induces Apoptosis of Osteosarcoma Cells through PI3K/Akt/mTOR Pathway [J].

Chen, Zhuo ;

Ni, Renhua ;

Hu, Yuanyu ;

Yang, Yiyuan ;

Tian, Yun .

ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2024, 24 (17) :1288-1294

← 1 2 3 4 5 →